AMNIOmics: A Prenatal Rapid Genome Validation Study
NCT05834621 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-09-05
Summary
The purpose of this study is to validate Whole Genome Sequencing (WGS) on amniotic fluid to reduce the time to diagnosis and enhance the care for the fetus/neonate.
Conditions
- Multiple Anomalies of Fetus
- Genetic Predisposition Suspected
- Amniocentesis Affecting Fetus or Newborn
- Family Members
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Myra Wick, MD, PhD · Mayo Clinic
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-07
- Primary Completion
- 2025-01-07
- Completion
- 2025-01-07
More Related Trials
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
NCT01708746 ·Status: COMPLETED
-
Pregnant Women s Views About the Ethics of Prenatal Whole Genome Sequencing
NCT03105492 ·Status: COMPLETED
-
Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
NCT00700219 ·Status: UNKNOWN
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Prenatal Genetic Diagnosis by Genomic Sequencing
NCT03936101 ·Status: COMPLETED
-
Perinatal Precision Medicine
NCT03211039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses
NCT00127946 ·Status: UNKNOWN ·Phase: PHASE3
-
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189 ·Status: TERMINATED
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Identification of Microbial DNA in Maternal Plasma After PPROM
NCT04318470 ·Status: COMPLETED
-
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
NCT01736826 ·Status: COMPLETED
-
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 ·Status: TERMINATED
-
A Comparison of Rapid Immunoassays for the Detection of Ruptured Membranes
NCT02208011 ·Status: COMPLETED
-
Collection of Whole Blood Specimens in Pregnant Women
NCT03590678 ·Status: COMPLETED
-
Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities
NCT05618431 ·Status: RECRUITING ·Phase: NA
-
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393 ·Status: COMPLETED
-
The Role of Cytokines in Apparently Normal Pregnancies
NCT01098214 ·Status: WITHDRAWN
-
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
NCT02808494 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling
NCT05453474 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing
NCT04584047 ·Status: COMPLETED ·Phase: NA